🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Smartphone Application for University Students With Binge Drinking Behavior

RecruitingNAAges 18 Years - 25 YearsAllCentre Hospitalier Universitaire, Amiens
NCT06084832 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Alcohol use is a causal factor in more than 200 diseases and injury conditions (see ICD-10) and in France, alcohol is the first cause of hospitalization. Binge drinking (BD) has emerged as a major public health issue among student populations and is associated with negative consequences and social, cognitive and brain alterations. More than half of French university students have reported BD in the past month and are at increased risk of several alcohol-related consequences such as memory and sleep impairments, and reduced quality of life. BD is also a major risk factor in the development of alcohol addiction, with individual and environmental factors playing a role that is still poorly understood. Moreover, most students and young adults are reluctant to seek interventions when it is provided by health care professionals (only 4-5%) and have poor insight with regard to their alcohol use

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Students between 18 and 25 years old * AUQ score greater than or equal to 24, and AUDIT score greater than or equal to 3 for its first 3 items. Drinking details with the DDQ when necessary. * BD behavior: at least one occasion with 6 or more drinks in the last 3 months. * Consent to be included in the study * Affiliated to social security Exclusion Criteria: * Not having a smartphone with an Apple or Android system. * Previous use of the MyDéfi smartphone application * Declaration of a psychiatric / neurologic condition * Pregnant, parturient or breastfeeding woman * Subject under guardianship, curators or restricted under public law
💊

What it tests

  • blood microsampling
📍

Where

1 site
CHU Amiens Picardie
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy